NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Old Version 4

changes.mady.by.user Morrissey, Laurie (NIH/NCI) [C]

Saved on

compared with

New Version 5

changes.mady.by.user Morrissey, Laurie (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Funda Meric-Bernstam is Chair of the Department of Investigational Cancer Therapeutics — the Phase I Program at MD Anderson Cancer Center, the Medical Director of the Institute for Personalized Cancer Therapy (IPCT), Professor in the Division of Cancer Medicine, and Professor in the Department of Breast Surgical Oncology.    She has a basic and translational research program that is focused on molecular therapeutics, predominantly on PI3K/Akt/mTOR signaling, to delineate the mechanism of action of each agent targeting this pathway and the molecular alterations useful to prospectively identify patients who will benefit most from each agent, and optimal combination therapies.

...

Speaker: Funda Meric-Bernstam, M.D.

Date: Wednesday, Septembe September 28, 2016

Time: 11 AM – 12 PM ET

...